Scala Biodesign
PrivateLast Round
Series A
Mar 31, 2026
Total Funding Raised
$21.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scala Biodesign is a biotechnology company that provides a computational platform using physics-based modeling, AI, and biological data analysis to engineer and design proteins for the pharmaceutical, chemical, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scala Biodesign Comparables
Compare Scala Biodesign with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cradle | 86% | |
| Biomatter | 84% | |
| OpenProtein.AI | 82% |
Scala Biodesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2026 | ||||
| Seed | Sep 11, 2023 |
Key People
Founding team and executive leadership
Scala Biodesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Insight | Series A |
| Israel Innovation Authority | Series A |
| Grove Ventures | Series A |
| TLV Partners | Series A, Seed |
| Intel Ignite | Seed |
| Ignite DeepTech Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 49% MoM, reaching 4.8K.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 3.2K.
Scala Biodesign Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Scala Biodesign's valuation, stock price, and market status.
Is Scala Biodesign a public or private company?
Scala Biodesign is a private company.
What is the current stock price of Scala Biodesign?
Scala Biodesign is a private company, so its shares have no public market price. Caplight tracks Scala Biodesign's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scala Biodesign worth (valuation)?
Valuation information for Scala Biodesign is not publicly available.
Can I buy Scala Biodesign stock?
Scala Biodesign shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scala Biodesign's last funding round?
Scala Biodesign's most recent funding round was Series A on March 31, 2026.
Who are the main investors in Scala Biodesign?
Key investors in Scala Biodesign include Grove Ventures, TLV Partners.
Will Scala Biodesign IPO soon?
No public IPO plans have been announced for Scala Biodesign.
How can I track Scala Biodesign secondary market activity?
Caplight tracks bids, offers, and trades in Scala Biodesign's shares on secondary markets.